These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32612383)

  • 1. Down-Regulation of Ribosomal Protein RPS21 Inhibits Invasive Behavior of Osteosarcoma Cells Through the Inactivation of MAPK Pathway.
    Wang T; Wang ZY; Zeng LY; Gao YZ; Yan YX; Zhang Q
    Cancer Manag Res; 2020; 12():4949-4955. PubMed ID: 32612383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of CD44 inhibits proliferation, migration and invasion of osteosarcoma cells accompanied by downregulation of cathepsin S.
    Kong L; Ji H; Gan X; Cao S; Li Z; Jin Y
    J Orthop Surg Res; 2022 Mar; 17(1):154. PubMed ID: 35264209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a prognostic risk model for osteosarcoma and mechanistic investigation.
    Jiang H; Zhao X; Zang J; Wang R; Gao J; Chen J; Yu T
    Front Pharmacol; 2024; 15():1399625. PubMed ID: 38720781
    [No Abstract]   [Full Text] [Related]  

  • 4. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
    Jia F; Zhang Z; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-337-5p participates in the development and progression of osteosarcoma via ERBB, MAPK and VEGF pathways.
    Tian ZG; Zhuang Y; Jin Z; Zhou F; Zhu LF; Shen PC
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5460-5470. PubMed ID: 30229817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDX10 overexpression predicts worse prognosis in osteosarcoma and its deletion prohibits cell activities modulated by MAPK pathway.
    Shi JH; Hao YJ
    Biochem Biophys Res Commun; 2019 Mar; 510(4):525-529. PubMed ID: 30738579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
    Liu ZB; Wang JA; Lv RQ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragalus polysaccharides decrease proliferation, migration, and invasion but increase apoptosis of human osteosarcoma cells by up-regulation of microRNA-133a.
    Chu Y; Fang Y; Chi J; Li J; Zhang D; Zou Y; Wang Z
    Braz J Med Biol Res; 2018 Nov; 51(12):e7665. PubMed ID: 30462772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-1269a promotes the occurrence and progression of osteosarcoma by inhibit-ing TGF-β1 expression.
    Yu SN; Miao YY; Zhang BT; Dai YM; Liu L; Gao ZL; Liu GF
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):972-981. PubMed ID: 30779063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSKH1 affects proliferation and invasion of osteosarcoma cells via the p38/MAPK signaling pathway.
    Zhu X; Jiang C; Wang Z; Zhu X; Yuan F; Yang Y
    Oncol Lett; 2023 Apr; 25(4):144. PubMed ID: 36936027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of ribosomal protein S21 as a potential prognostic and immunotherapy biomarker for hepatocellular carcinoma.
    Pan J; Zhang C; Sa G; Huang H; Zhang R; Chen F
    Asian J Surg; 2024 Jul; ():. PubMed ID: 38987142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of long-non-coding RNA ANCR suppresses the migration and invasion of osteosarcoma cells by activating the p38MAPK signalling pathway.
    Liu B; Zhao H; Zhang L; Shi X
    BMC Cancer; 2019 Nov; 19(1):1112. PubMed ID: 31727012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Downregulation of Herg1 suppresses osteosarcoma proliferation and invasion by targeting Hippo signaling pathway].
    Chen ZD; Ye WB; Zeng WR; Song C; Song W; Zhang YM; Wu J
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):338-345. PubMed ID: 31137166
    [No Abstract]   [Full Text] [Related]  

  • 14. GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma.
    Gu Q; Luo Y; Chen C; Jiang D; Huang Q; Wang X
    Exp Cell Res; 2019 Nov; 384(1):111619. PubMed ID: 31525341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2.
    Chen Z; Zhao G; Zhang Y; Ma Y; Ding Y; Xu N
    J BUON; 2018; 23(6):1816-1824. PubMed ID: 30610808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA hsa_circ_0069117 suppresses proliferation and migration of osteosarcoma cells lines via miR-875-3p/PF4V1 axis.
    Zhang Z; Zhou L; Zhou S; Li X
    J Orthop Surg Res; 2022 Jan; 17(1):37. PubMed ID: 35062989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oncogenic role of REG γ is exerted by activating the Wnt/β-catenin signaling pathway in osteosarcoma.
    Yin Z; Peng Z; Wang Z; Meng Q
    Am J Transl Res; 2020; 12(2):563-573. PubMed ID: 32194904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-127-3p inhibits cell growth and invasiveness by targeting ITGA6 in human osteosarcoma.
    Wang D; Tang L; Wu H; Wang K; Gu D
    IUBMB Life; 2018 May; 70(5):411-419. PubMed ID: 29573114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MFAP2 induces epithelial-mesenchymal transformation of osteosarcoma cells by activating the Notch1 pathway.
    Jiang S; Zheng Z; Yuan B; Yan R; Yao Q; Chen H; Zhang Y; Lei Y; Liang H
    Transl Cancer Res; 2024 Jun; 13(6):2847-2859. PubMed ID: 38988940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-222 contributed to cell proliferation, invasion and migration via regulating YWHAG in osteosarcoma.
    Chu YW; Wang CR; Weng FB; Yan ZJ; Wang C
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2588-2597. PubMed ID: 29771442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.